Name: Latest research reports of Ajanta Pharma Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: ICICI Securities Limited

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2622.5000 20.25 (0.78%)

NSE Mar 19, 2025 15:31 PM

27.83% Gain from 52W Low

Volume: 59,405

Ajanta Pharma Ltd.

30 Jul 2021

2622.50

0.78%

Ajanta Pharmaceuticals

Buy: Ajanta Pharma Ltd.

Target

ICICI Securities Limited

Domestic formulations constitute 30% of the total consolidated turnover and is segregated into branded formulations & institutional business Asia accounts for ~35% of export formulations, Africa 33% & US 32%. The...

Ajanta Pharma Ltd. has an average target of 2987.67 from 3 brokers.